Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight ...

Young people with severe obesity who underwent weight-loss surgery at age 19 or younger continued to see sustained weight loss and resolution of common obesity-related comorbidities 10 years later, ...

Wegovy® is the only version of semaglutide that is FDA-approved for weight loss, while Ozempic® and other forms of the drug are primarily used for managing diabetes. However, some doctors prescribe ...

Researchers have found "tremendous long-term outcomes" for teenagers who underwent surgery to treat their severe obesity a ...

She has spent most of her career counseling patients with diabetes, across all ages ... Not experiencing weight loss could be due to several factors, such as the medications you are taking ...

Weight-loss surgery in adolescents with severe obesity can lead to long-term health benefits, such as more frequent remission ...

New research shows adolescents also are less likely to develop type 2 diabetes after gastric bypass and sleeve gastrectomy ...

A new study suggests that weekly self-injections of the weight loss drug semaglutide could reduce knee pain from moderate osteoarthritis by nearly 50%.

Pfizer (PFE) offered up some more details on its weight loss drug pipeline on Tuesday during a call with investors after it ...

Employers are rushing to Omada to get the startup's help managing patients on costly drugs like Ozempic.

GLP-1 drugs like Wegovy (NVO) might help with weight loss, but they aren’t leading to lower health care costs yet, according ...

Eli Lilly missed Wall Street estimates for its popular weight-loss and diabetes drugs on Wednesday, hit by a decrease in U.S.